AstraZeneca agrees to supply Europe Union members with 400 million doses of Covid-19 vaccine

Europe’s Inclusive Vaccines Alliance (IVA), a group formed by the Netherlands, Germany, France and Italy, concluded a contract with AstraZeneca to provide 400 million doses of a possible vaccine developed by the University of Oxford. If the trial results convince regulators the vaccine is safe and effective, deliveries are expected to start by the end of 2020.
The company reached similar agreements with the United Kingdom and with the United States.